“…In 2018, Shuoshan Xie et al discovered that IFITM2, LY6E, DDX58, and IFI6 were expressed at higher levels in the muscle tissue of patients with DM, indicating the important role of the interferon (IFN) signaling pathway in the pathogenesis of DM [ 11 ]. In 2020, one bioinformatic study has concluded that DEGs between DM and healthy control (HC) are primarily enriched in immune-related pathways [ 12 ]. Another bioinformatic study has revealed 10 hub genes, including ISG15, DDX58, IFIT3, CXCL10, and STAT1, and indicated that proinflammatory factors and IFN family proteins are highly associated with DM [ 13 ].…”